Free Trial
Tada emoji MarketBeat All Access — Now Just $5.00 for 5 Weeks

Urogen Pharma (URGN) SEC Filings & 10K Form

Urogen Pharma logo
$20.08 -0.03 (-0.15%)
Closing price 08/14/2025 04:00 PM Eastern
Extended Trading
$20.08 0.00 (0.00%)
As of 04:22 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Compare

Recent Urogen Pharma SEC Filings

Export to Excel
DateFilerForm TypeView
08/13/2025
8:58 AM		Schoenberg Mark (Reporting)
Urogen Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/12/2025
3:30 PM		Paradigm Biocapital Advisors LP (Filed by)
Urogen Pharma (Subject)
Form SCHEDULE 13G
08/07/2025
7:01 AM		Urogen Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/07/2025
7:05 AM		Urogen Pharma (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/29/2025
6:29 AM		Schoenberg Mark (Reporting)
Urogen Pharma (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/29/2025
6:23 AM		Smith Jason Drew (Reporting)
Urogen Pharma (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/16/2025
6:02 PM		BlackRock, Inc. (Filed by)
Urogen Pharma (Subject)
Form SCHEDULE 13G/A
07/16/2025
8:32 AM		Urogen Pharma (Filer)
Form ARS
07/15/2025
3:56 PM		Urogen Pharma (Filer)
Form DEF 14A
07/03/2025
3:16 PM		Urogen Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/13/2025
10:38 AM		Cowen Financial Products LLC (Filed by)
Urogen Pharma (Subject)
Form SCHEDULE 13G
06/13/2025
7:00 AM		Urogen Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/11/2025
8:14 AM		Schoenberg Mark (Reporting)
Urogen Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2025
8:27 AM		Schoenberg Mark (Reporting)
Urogen Pharma (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/09/2025
6:19 PM		Monograph Capital Holdings Advisors, LLC (Filed by)
Urogen Pharma (Subject)
Form SCHEDULE 13D/A
05/12/2025
8:02 AM		Adage Capital Management, L.P. (Filed by)
Urogen Pharma (Subject)
Form SCHEDULE 13G/A
05/12/2025
7:06 AM		Urogen Pharma (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/12/2025
7:03 AM		Urogen Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/17/2025
12:23 PM		MENORA MIVTACHIM HOLDINGS LTD. (Filed by)
Urogen Pharma (Subject)
Form SCHEDULE 13G/A
03/10/2025
3:32 PM		Urogen Pharma (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/10/2025
7:02 AM		Urogen Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/20/2025
7:05 AM		Urogen Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/12/2025
8:34 AM		Adage Capital Management, L.P. (Filed by)
Urogen Pharma (Subject)
Form SCHEDULE 13G/A
02/05/2025
9:09 AM		MORGAN STANLEY (Filed by)
Urogen Pharma (Subject)
Form SCHEDULE 13G/A
02/04/2025
10:49 AM		Barrett Elizabeth A. (Reporting)
Urogen Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/04/2025
10:51 AM		Smith Jason Drew (Reporting)
Urogen Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/04/2025
10:53 AM		Schoenberg Mark (Reporting)
Urogen Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/14/2025
6:01 AM		Urogen Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/18/2024
5:16 AM		Pontifax Management III G.P. Ltd. (0001726335) (Filed by)
Urogen Pharma (Subject)
Form SC 13D/A
11/14/2024
6:46 PM		Point72 Asset Management, L.P. (Filed by)
Urogen Pharma (Subject)
Form SC 13G/A
11/14/2024
4:46 PM		RA CAPITAL MANAGEMENT, L.P. (Filed by)
Urogen Pharma (Subject)
Form SC 13G/A
11/14/2024
11:04 AM		MENORA MIVTACHIM HOLDINGS LTD. (Filed by)
Urogen Pharma (Subject)
Form SC 13G/A
11/14/2024
7:37 AM		COWEN AND COMPANY, LLC (Filed by)
Urogen Pharma (Subject)
Form SC 13G/A
11/14/2024
5:44 AM		RTW INVESTMENTS, LP (Filed by)
Urogen Pharma (Subject)
Form SC 13G/A
11/12/2024
8:30 AM		Adage Capital Management, L.P. (Filed by)
Urogen Pharma (Subject)
Form SC 13G
11/08/2024
1:17 PM		BlackRock, Inc. (Filed by)
Urogen Pharma (Subject)
Form SC 13G
11/06/2024
12:50 PM		MORGAN STANLEY (Filed by)
Urogen Pharma (Subject)
Form SC 13G
11/06/2024
7:01 AM		Urogen Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/06/2024
7:04 AM		Urogen Pharma (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/24/2024
1:02 PM		BlackRock, Inc. (Filed by)
Urogen Pharma (Subject)
Form SC 13G
10/09/2024
3:21 PM		Degnan Chris (Reporting)
Urogen Pharma (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off (Ad)

Right now, we’re witnessing a monumental shift in the world.

Our No. 1 AI Pick is currently trading for pennies on the dollar compared to Nividia.
10/09/2024
3:22 PM		Degnan Chris (Reporting)
Urogen Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/09/2024
7:18 AM		Urogen Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/24/2024
3:15 PM		Urogen Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/12/2024
12:51 PM		Smith Jason Drew (Reporting)
Urogen Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/12/2024
12:54 PM		Schoenberg Mark (Reporting)
Urogen Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/12/2024
12:50 PM		Kim Dong (Reporting)
Urogen Pharma (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/10/2024
6:16 AM		Schoenberg Mark (Reporting)
Urogen Pharma (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/15/2024
7:00 AM		Urogen Pharma (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools

Related Companies
SEC Filings Tools

This page (NASDAQ:URGN) was last updated on 8/15/2025 by MarketBeat.com Staff
From Our Partners
Trump’s national nightmare is here
Porter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...
Porter & Company | Sponsored
Alex’s “Next Magnificent Seven” stocks
The original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...
The Oxford Club | Sponsored
The Robotics Revolution has arrived … and one $7 stock could take off as a result.
Something big is brewing in Washington. According to my research, an executive order from President Trump c...
Weiss Ratings | Sponsored
INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off
Right now, we’re witnessing a monumental shift in the world.
Traders Agency | Sponsored
GENIUS Act: Cancel Your Money?
A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...
Priority Gold | Sponsored
Elon’s Secret Social Security Bombshell
To All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...
Banyan Hill Publishing | Sponsored
Trump set to Boost Social Security Checks by 400%?
If you're collecting or planning to collect social security... You should see this presentation about Presi...
InvestorPlace | Sponsored
BONUS GUIDE - Ben Stein Prepares For the Next Financial Crisis
With inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...
Goldco Precious Metals | Sponsored